(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PAZYLPRO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

PAZYLPRO

ST13

US500000079314255

Class

5

Filing

79314255

Registration

6829729

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

34

Latest update

11/06/2022

Trademark type

Word

Nice classes

5

Filing date

05/07/2021

Registration date

08/30/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/30/2022

Last transaction

08/30/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

CH

Examiner

STEEL, ALYSSA PALADINO

Law office

N60

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

NOVARTIS AG

Representatives

Maury M. Tepper, III Tepper & Eyster, PLLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Publications

History of USPTO decisions and trademark events.

34 publications found

GPNX

NOTIFICATION PROCESSED BY IB

11/06/2022

FICS

FINAL DISPOSITION NOTICE SENT TO IB

10/12/2022

FIMP

FINAL DISPOSITION PROCESSED

10/12/2022

GPAR

GRANT OF PROTECTION CREATED, TO BE SENT TO IB

09/29/2022

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

08/30/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

08/30/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/14/2022

PUBO

PUBLISHED FOR OPPOSITION

06/14/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/25/2022

CORR

CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED

05/13/2022

FINA

FINAL DISPOSITION REVIEWED - NO ACTION REQUIRED BY OFFICE

05/02/2022

ATRV

ATTORNEY REVIEW COMPLETED

03/29/2022

ATRQ

ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED

03/28/2022

CRTP

REG. CANCELLED - RESTORED TO PENDENCY

02/22/2022

APET

ASSIGNED TO PETITION STAFF

02/22/2022

RCII

REQUEST TO CANCEL INADVERTENTLY ISSUED REGISTRATION RECEIVED

02/17/2022

GPAR

GRANT OF PROTECTION CREATED, TO BE SENT TO IB

02/03/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

01/04/2022

CRCV

CORRECTION TRANSACTION RECEIVED FROM IB

11/23/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/19/2021

PUBO

PUBLISHED FOR OPPOSITION

10/19/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/29/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/14/2021

DOCK

ASSIGNED TO EXAMINER

09/14/2021

MAFR

APPLICATION FILING RECEIPT MAILED

07/10/2021

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/09/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/09/2021

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

07/09/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/09/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/09/2021

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/09/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/06/2021

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

07/04/2021

SDRC

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

06/25/2021

Continuous trademark protection

Get notified about every new filing that threatens PAZYLPRO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.